Effect of taurine and coenzyme Q10 in patients with acute myocardial infarction

Advances in Experimental Medicine and Biology

Volumn 526, Issue , 2003, Pages 41-48

  Singh, R B ^a   Kartikey, K ^a   Charu, A S ^a   Niaz, M A ^a   Schaffer, S ^b  

^a Medical Hospital and Research Centre Moradabad   (India)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID; CYCLIC AMP; TAURINE; UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

ACUTE HEART INFARCTION; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; DRUG EFFECT; HEART DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; TAURINE; UBIQUINONE;

EID: 1542463943     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0077-3_6     Document Type: Article

References (24)

1. Ceremuzynski, L., 1981, Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ. Res. 48:765-76.
2. Singh, R.B., Niaz, M.A., Rastogi, S.S., Sharma, J.P., Kumar, Bishnoi, I., Beegum, R., 1994, Plasma levels of antioxidant vitamins and oxidative stress in patients with suspected acute myocardial infarction. Acta Cardiol. 49:441-52.
3. Grech, E.D., Jackson, M., Ramsdale, D.R., 1995, Br. Med. J. 310:477-78.
4. Singh, R.B., Wander, G.S., Rastogi, A., Shukla, P.K., Mittal, A., Sharma, J.P., Mehrotra, S.K., Kapoor, R., Chopra, R.K., 1998, Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc. Drug Ther. 12:347-53.
5. Crass, M.F., Lombardini, J.B., 1978, Release of tissue taurine from the oxygen deficient perfused rat heart. Proc. Soc. Exp. Ther. 157:486-88.
6. Crass, M.F., Lombardini, J.B., 1977, Loss of cardiac muscle taurine after acute left ventricular ischaemia. Life Science 21:951-58.
7. Lombardini, J.B., 1980, Effects of isoproterenol and methoxamine on the contents of taurine in rat tissue. J. Pharmacol. Exp. Ther. 213:399-405.
8. Lombardini, J.B., Cooper, M.W., 1981, Elevated blood taurine levels in acute evolving myocardial infarction. J. Lab. Clin. Med. 98:849-59.
9. Bhatanagar, S.K., Welty, J.D., Al-Ysuf, A.R., 1990, Significance of blood taurine levels in patients with first time acute ischemic cardiac pain. Int. J. Cardiol. 27:361-66.
10. Cooper, M.W., Lombardini, J.B., 1981, Elevated blood taurine levels after myocardial infarction or cardiovascular surgery. Is there any significance? Adv. Exp. Med. Biol. 139:191-205.
11. Pion, P.D., Kittleson, M.D., Rogers, Q.R., Morris, J.G., 1987, Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764-68.
12. Allo S.N., Bagby, L., Schaffer, S.W., 1997, Taurine depletions novel mechanism for cardioprotection from regional ischemia. Am. J. Physiol. 273: H1956-61.
13. Azumo, J., Sawamura, A., Awata, N., Hasegawa, H., Ogura, K., Harada, H., Ohta, H., Yamayuchi, K., Kishimoto, S., Yamagami, T., Ueda, T., Ishiyama, T., 1983, Double blind randomized crossover trial of taurine in congestive heart failure. Curr. Ther. Res. 34:543-58.
14. Kramer, J.H., Chovan, J.P., Schaffer, S.W., 1981, Effect of taurine on calcium paradox and ischemic heart failure. Am. J. Physiol. 240:H238-H246.
15. Raschake, P., Massoudy, P., Becker, B.F., 1995, Taurine protects the heart from neutrophil-induced reperfusion injury. Free Rad. Biol. Med. 19:461-71.
16. Takihara, K., Azuma, J., Awata, N., Ohta, H., Hamaguchi, T., Sawamura, A., Tanaka, Y., Kishimoto, S., Sperelakis, N., 1986, Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am. Heart J. 112:1278-84.
17. Kaikonen, J., Toumainen, T.P., Nyyssonen, K., Salonen, J.T., 2002, Coenzyme Q10: absorption, antioxidative properties, determinants and plasma levels. Free Rad. Res. 36(Suppl):389-99.
18. Schaffer, S., Takahashi, K., Azuma, J., 2000, Role of osmoregulation in the actions of taurine. Amino Acids 19:527-46.
19. Lake, N., deRoode, M., Nattel, S., 1987, Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sci. 40:997-1005.
20. Green, T.R., Fellman, J.H., Eicher, A.L., Pratt, K.L., 1991, Antioxidant role and subcellular location of hyporaurine and taurine in human neutrophils. Biochem. Biophys. Acta 1073:91-97.
21. Milei, J., Ferreira, R., Llesuy, S., 1992, Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am. Heart J. 123:339-45.
22. McCarty, M.F., 1999, The reported clinical utility of taurine in ischemic disorders may reflect a down regulation of neutrophil activation and adhesion. Med. Hypotheses 53:290-99.
23. Azuma, M., Takahashi, K., Fukuda, T., Ohyabu, Y., Yamamoto, I., Kim, S., Iwao, H., Schaffer, S.W., and Azuma, J., 2000, Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur. J. Pharmacol. 403: 181-188.
24. Schaffer, S.W., Solodushko, V. and Kakhniashvili, D., 2002, Beneficial effect of taurine depletion on osmotic, sodium and calcium loading. Am. J. Physiol. 282: C1113-C1120.